Phase 4 Antibody Clinical Trials
5 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–5 of 5 trials
Recruiting
Phase 4
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Amgen300 enrolled76 locationsNCT06072482
Recruiting
Phase 4
Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
COPDAlpha 1-AntitrypsinAntibody Deficiency
University of Alabama at Birmingham30 enrolled1 locationNCT07135427
Completed
Phase 4
Evaluating typhoid vaccine responses in specific antibody deficiency patients receiving immunoglobulin replacement.
Specific antibody deficiency
Melbourne Health40 enrolled3 locationsACTRN12621001059853
Terminated
Phase 4
A Randomised Controlled trial of intravenous immunoglobulin (IVIg) compared with pulse methyl-prednisolone for the treatment of chronic active antibody mediated rejection
chronic active antibody mediated rejection of the renal allograft
Dr William Mulley50 enrolled7 locationsACTRN12612000252819
Completed
Phase 4
The response of vasculitis patients to influenza vaccination compared to healthy individuals
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
Royal Adelaide Hospital100 enrolled1 locationACTRN12608000440325